Seeking Alpha

The FDA approves Bydureon - opening up the door for production and marketing of the diabetes...

The FDA approves Bydureon - opening up the door for production and marketing of the diabetes shot by partners Alkermes (ALKS) and Amylin (AMLN). Shares of both firms are still halted.
Comments (1)
  • jeffa55
    , contributor
    Comment (1) | Send Message
     
    This is prolly not going to open up until Monday now......
    27 Jan 2012, 11:10 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|